283 related articles for article (PubMed ID: 25804938)
1. Social intentions in Parkinson's disease patients: A kinematic study.
Straulino E; Scaravilli T; Castiello U
Cortex; 2015 Sep; 70():179-88. PubMed ID: 25804938
[TBL] [Abstract][Full Text] [Related]
2. Dopamine depletion affects communicative intentionality in Parkinson's disease patients: Evidence from action kinematics.
Straulino E; Scaravilli T; Castiello U
Cortex; 2016 Apr; 77():84-94. PubMed ID: 26922506
[TBL] [Abstract][Full Text] [Related]
3. It's all in the type of the task: Dopamine modulates kinematic patterns during competitive vs. cooperative interaction in Parkinson's disease.
Straulino E; Scaravilli T; Bulgheroni M; D'Amico E; Castiello U
Neuropsychologia; 2016 Dec; 93(Pt A):106-115. PubMed ID: 27756693
[TBL] [Abstract][Full Text] [Related]
4. Effects of disease progression and L-dopa therapy on the control of reaching-grasping in Parkinson's disease.
Negrotti A; Secchi C; Gentilucci M
Neuropsychologia; 2005; 43(3):450-9. PubMed ID: 15707620
[TBL] [Abstract][Full Text] [Related]
5. The reach-to-grasp movement in Parkinson's disease before and after dopaminergic medication.
Castiello U; Bennett KM; Bonfiglioli C; Peppard RF
Neuropsychologia; 2000; 38(1):46-59. PubMed ID: 10617291
[TBL] [Abstract][Full Text] [Related]
6. Subthalamic nucleus stimulation modulates motor cortex oscillatory activity in Parkinson's disease.
Devos D; Labyt E; Derambure P; Bourriez JL; Cassim F; Reyns N; Blond S; Guieu JD; Destée A; Defebvre L
Brain; 2004 Feb; 127(Pt 2):408-19. PubMed ID: 14691060
[TBL] [Abstract][Full Text] [Related]
7. Parkinson's disease duration determines effect of dopaminergic therapy on ventral striatum function.
MacDonald AA; Monchi O; Seergobin KN; Ganjavi H; Tamjeedi R; MacDonald PA
Mov Disord; 2013 Feb; 28(2):153-60. PubMed ID: 23165957
[TBL] [Abstract][Full Text] [Related]
8. Levodopa-sensitive, dynamic changes in effective connectivity during simultaneous movements in Parkinson's disease.
Palmer SJ; Eigenraam L; Hoque T; McCaig RG; Troiano A; McKeown MJ
Neuroscience; 2009 Jan; 158(2):693-704. PubMed ID: 18722512
[TBL] [Abstract][Full Text] [Related]
9. Influence of basal ganglia on upper limb locomotor synergies. Evidence from deep brain stimulation and L-DOPA treatment in Parkinson's disease.
Crenna P; Carpinella I; Lopiano L; Marzegan A; Rabuffetti M; Rizzone M; Lanotte M; Ferrarin M
Brain; 2008 Dec; 131(Pt 12):3410-20. PubMed ID: 18952669
[TBL] [Abstract][Full Text] [Related]
10. l-DOPA changes ventral striatum recruitment during motor sequence learning in Parkinson's disease.
Kwak Y; Müller ML; Bohnen NI; Dayalu P; Seidler RD
Behav Brain Res; 2012 Apr; 230(1):116-24. PubMed ID: 22343069
[TBL] [Abstract][Full Text] [Related]
11. Levodopa enhances synaptic plasticity in the substantia nigra pars reticulata of Parkinson's disease patients.
Prescott IA; Dostrovsky JO; Moro E; Hodaie M; Lozano AM; Hutchison WD
Brain; 2009 Feb; 132(Pt 2):309-18. PubMed ID: 19050033
[TBL] [Abstract][Full Text] [Related]
12. Three-dimensional gait biomechanics in Parkinson's disease: evidence for a centrally mediated amplitude regulation disorder.
Morris M; Iansek R; McGinley J; Matyas T; Huxham F
Mov Disord; 2005 Jan; 20(1):40-50. PubMed ID: 15390033
[TBL] [Abstract][Full Text] [Related]
13. Levodopa reinstates connectivity from prefrontal to premotor cortex during externally paced movement in Parkinson's disease.
Herz DM; Siebner HR; Hulme OJ; Florin E; Christensen MS; Timmermann L
Neuroimage; 2014 Apr; 90():15-23. PubMed ID: 24269570
[TBL] [Abstract][Full Text] [Related]
14. Hand preshaping in Parkinson's disease: effects of visual feedback and medication state.
Schettino LF; Adamovich SV; Hening W; Tunik E; Sage J; Poizner H
Exp Brain Res; 2006 Jan; 168(1-2):186-202. PubMed ID: 16041510
[TBL] [Abstract][Full Text] [Related]
15. The effect of L-dopa in Parkinson's disease as revealed by neurophysiological studies of motor and sensory functions.
Suppa A; Bologna M; Conte A; Berardelli A; Fabbrini G
Expert Rev Neurother; 2017 Feb; 17(2):181-192. PubMed ID: 27477028
[TBL] [Abstract][Full Text] [Related]
16. A model of human aiming movements applied to Parkinson's disease.
Suri RE; Albani C; Glattfelder AH
Technol Health Care; 1997 Jul; 5(3):177-90. PubMed ID: 9263367
[TBL] [Abstract][Full Text] [Related]
17. Dopaminergic modulation of cognitive function-implications for L-DOPA treatment in Parkinson's disease.
Cools R
Neurosci Biobehav Rev; 2006; 30(1):1-23. PubMed ID: 15935475
[TBL] [Abstract][Full Text] [Related]
18. Response to sensory uncertainty in Parkinson's disease: a marker of cerebellar dysfunction?
Stevenson JK; Oishi MM; Farajian S; Cretu E; Ty E; McKeown MJ
Eur J Neurosci; 2011 Jan; 33(2):298-305. PubMed ID: 21155903
[TBL] [Abstract][Full Text] [Related]
19. Hand coordination as a quantitative measure of motor abnormality and therapeutic response in Parkinson's disease.
Benice TS; Lou JS; Eaton R; Nutt J
Clin Neurophysiol; 2007 Aug; 118(8):1776-84. PubMed ID: 17576094
[TBL] [Abstract][Full Text] [Related]
20. Basal ganglia, dopamine and temporal processing: performance on three timing tasks on and off medication in Parkinson's disease.
Jones CR; Malone TJ; Dirnberger G; Edwards M; Jahanshahi M
Brain Cogn; 2008 Oct; 68(1):30-41. PubMed ID: 18378374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
